MarketInOut Stock Screener Log In | Sign Up
 

Daxor Corp

NASDAQ • Healthcare • Medical Instruments & Supplies • Quote as of 10/23/2026
Daxor Corp stock price and volume chart

Company Profile

IndustryMedical Instruments & Supplies
SectorHealthcare
ExchangeNASDAQ
Market Capitalization54 mln
Float2.97 mln
Earnings Date03/03/2027

EPS

1.10
Decent

P / E

8.41
Undervalued

Piotroski F-Score

4 / 9
Borderline

Relative Strength

9 / 100
Severely lagging

Pre-Tax Margin

4,022%
Exceptional margin

ROE

14.01
Moderate

Business Description

Daxor Corporation, headquartered in Oak Ridge, Tennessee, is a medical technology company focused on blood volume measurement. Its main product is the BVA-100 Blood Volume Analyzer, which works alongside Volumex, a single-use diagnostic injection kit, to give clinicians accurate readings of a patient's blood volume. Founded in 1971 and originally called Idant Corporation, the company now operates as part of the Estate of Joseph Feldschuh.

Key Fundamentals

EPS1.10
P/E8.41
ROE14.01
RPS0.00
ROIC14.60
ROA13.97
Interest Cover1,862
EBITDA, mln6.23
EV / EBITDA8.20
EV / EBIT8.20
Revenue, mln0.16
EV / Revenue330

Quote Details

Last 9.25
Change -0.15 (-1.6%)
Open 9.68
Volume 20,626
Turnover 190,790
Average Volume 13,791

Financial Ratios

Pre-Tax Profit Margin4,022
Leverage Ratio1.00
Current Ratio245
Price / Book1.27
Price / Tangible Book1.27
Price / Sales363

Financial Strength

Altman Z-Score335
Piotroski F-Score 4 / 9
Price to Intrinsic Value5.98
Price to Graham Number0.72
Shiller PE Ratio29.61
Short Ratio0.16
Short % of Float0.23

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -7.96% 5 / 100   
1 Month -18.79% 6 / 100   
2 Months -12.16% 17 / 100   
6 Months -2.32% 39 / 100   
1 Year -28.63% 9 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog